TrialLung2023

The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough.

Lorcan McGarvey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.